000 | 01462 a2200409 4500 | ||
---|---|---|---|
005 | 20250515055251.0 | ||
264 | 0 | _c20070522 | |
008 | 200705s 0 0 eng d | ||
022 | _a0090-8258 | ||
024 | 7 |
_a10.1016/j.ygyno.2007.01.009 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBader, Arnim A | |
245 | 0 | 0 |
_aLong-term follow-up after neoadjuvant chemotherapy for high-risk cervical cancer during pregnancy. _h[electronic resource] |
260 |
_bGynecologic oncology _cApr 2007 |
||
300 |
_a269-72 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
650 | 0 | 4 | _aCesarean Section |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHysterectomy |
650 | 0 | 4 | _aLymph Node Excision |
650 | 0 | 4 | _aNeoadjuvant Therapy |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aPregnancy Complications, Neoplastic _xdrug therapy |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aUterine Cervical Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aVincristine _xadministration & dosage |
700 | 1 | _aPetru, Edgar | |
700 | 1 | _aWinter, Raimund | |
773 | 0 |
_tGynecologic oncology _gvol. 105 _gno. 1 _gp. 269-72 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ygyno.2007.01.009 _zAvailable from publisher's website |
999 |
_c16849308 _d16849308 |